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Abstract
Background: In 2006, the British government launched ‘Improving Access to Psychological Therapies’ (IAPT), a low
intensity cognitive behaviour therapy intervention (LiCBT) designed to manage people with symptoms of anxiety
and depression in the community. The evidence of the effectiveness of IAPT has been demonstrated in multiple
studies from the UK, USA, Australia and other countries. MindStep™ is the first adaptation of IAPT in Australia,
delivered completely by telephone, targeting people with a recent history of a hospital admission for mental
illnesses within the private health system. This paper reports on the outcome of the first 17 months of MindStep™
implemented across Australia from March 2016.
Methods: This prospective observational study investigated the MindStep™ program in a cohort of clients with a
recent hospitalisation for mental illnesses. The study used quantitative methods to compare pre-post treatment
clinical measures (N = 680) using Patient Health Questionnaire (PHQ-9) and the Generalised Anxiety Disorder
(GAD-7). This study also included in-depth interviews with participants (N = 14) and coaches (N = 4) to determine
the feasibility and acceptability of the program.
Results: Of the 867 clients referred to MindStep™, 757 had initial assessments by phone making an enrolment rate of
87.3%. Following assessment, 680 commenced treatment and of them, 427 (62.7%) completed treatment. According to
‘per-protocol’ analysis (N = 427), there was a large effect size for post-treatment PHQ-9 (d = 1.03) and GAD-7 (d = 0.99)
scores; reliable recovery rate was 62% (95% CI: 57–68%). For intent-to-treat analysis using multiple imputation (N = 680),
effect sizes were also large for pre-post treatment change: PHQ-9 (d = 0.78) and GAD-7 (d = 0.76). The reliable recovery
rate was 49% (95% CI: 45–54%). Qualitative findings supported these claims where participants were positive about
MindStep™ and found the telephone delivery and use of mental health coaches highly acceptable.
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Conclusions: MindStep™ has demonstrated encouraging outcomes that suggest LiCBT can be successfully delivered
to people with a history of hospital admissions for anxiety and depressive disorders and achieve target recovery rates
of > 50%. Other promising evaluation findings indicate the MindStep™ option is acceptable, feasible and safe within
the stepped models of mental health care delivery in Australia.
Keywords: Low-intensity cognitive behaviour therapy, Community mental health service, Depression, Anxiety,
Prevention and early intervention, Private health insurance, Hospital admission, Improving access to psychological
therapies
Background
In Australia, anxiety and depressive disorders are com-
mon, leading to significant burden on people’s lives and
the community [1]. The latest National Survey of Mental
Health and Wellbeing showed that around one million
adults (6.2%) experienced a 12-month depressive disorder
and over two million experienced a 12-month anxiety dis-
order (14.4%) in Australia (with a population of 16 mil-
lion) [2]. The survey also reported that only 40% of this
population accessed any healthcare services [2], despite an
annual AUD 974 million spent on health care costs and
another AUD 11.8 billion attributed to productivity loss
[3]. However, for people with chronic and recurring symp-
toms, transitioning care from acute hospitals to the com-
munity can be fragmented and difficult to navigate [4].
Existing service models produce unintended barriers to
accessing care [5, 6]. It is estimated that only one third of
people diagnosed with depression actually receive any for-
mal support [7], and up to 50% of these people may not
be receiving evidence-based treatments [7, 8].
With traditional therapist-led models of care and
ever-increasing demand, prevention and early interven-
tion are often neglected within the continuum of care.
Critics state that, “because of significant waiting lists
those people who might make the greatest gains from
Cognitive Behavioural Therapy (CBT) i.e. those with
mild to moderate depression, anxiety and panic, are least
likely to be referred…”([6], p., 676).
In 2006, the British government launched an innova-
tive program called ‘Improving Access to Psychological
Therapies’ (IAPT) to address this unmet demand for
treatment of anxiety and depression in the UK popula-
tion [9]. It was associated with the creation of a new
workforce to deliver early and low intensity interven-
tions consistent with the National Institute for Health
and Care Excellence (NICE) guideline recommendations
[10]. The potential effectiveness of this model has been
shown in a number of cohort studies in the UK, USA,
Australia and other countries [11–16], with recent litera-
ture specifying how it fits into stepped models of mental
health care [5]. Findings from a more recent Norwegian
study have further contributed to the emerging
evidence-base where recovery rates are reported from
both complete case and intent-to-treat perspectives
[17]. This and other previous studies provide a con-
duit for establishing high quality evidence within the
Australian context including public and private hospi-
tals, with the goal to improve client outcomes upon
discharge and future potential to reduce hospital
readmissions.
MindStep™
MindStep™1 is the latest adaptation of IAPT in Australia,
which is an ‘opt-in’ service offered to people from par-
ticipating private health insurance funds with a recent
hospital admission due to depression or anxiety. This is
the first application of IAPT in a private health insur-
ance context, to address symptom recovery and subse-
quent hospital utilisation.
It is delivered over 6–8 weeks, telephonically by LiCBT
coaches under close clinical supervision. The first clin-
ical assessment identifies suitability for the intervention
using a semi-structured clinical interview, including risk
assessment. Subsequent sessions follow a structured
guided LiCBT format between coach and client, using
the person’s own problem statements, goals, planned ac-
tions and workbook exercises, supported by guided
self-help, social prescribing to engage the person with
their social networks and signposting to community ser-
vices [11]. After initial assessment and up to six treat-
ment sessions, clients are offered a 1-month, 3-month
and 6-month follow-up to monitor whether improve-
ments are maintained. Baseline symptom scores for
Patient Health Questionnaire (PHQ-9), Generalized
Anxiety Disorder (GAD-7) and Work and Social Adjust-
ment Scale (WSAS) are obtained at each contact.
The average duration of an assessment is 1 h and dur-
ation of treatment sessions is approximately 30 min. The
service uses a proprietary software system to collect cli-
ent information, support case management and clinical
supervision of mental health coaches. More information
on the program can be found in the Additional file 1.
MindStep™ was launched in October 2015 and was
fully functional from March 2016. This paper reports on
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the first 17 months of MindStep™ outcome, implemented
across Australia starting from March 2016.
Study aims
The study aimed to assess:
1. The feasibility and acceptability of MindStep™ in the
Australian private health system; and
2. Whether MindStep™ can achieve benchmark
recovery rates of > 50% in people with recent
mental health hospital admission [18]
Methods
Study design
This prospective observational study investigated the
MindStep™ program in a cohort of clients with a recent
hospitalisation for mental illnesses. The study used
quantitative methods to compare pre-post treatment
clinical measures (N = 680) using Patient Health Ques-
tionnaire (PHQ-9) and the Generalised Anxiety Disorder
(GAD-7). This study also included in-depth interviews
with participants (N = 14) and coaches (N = 4) to deter-
mine the feasibility and acceptability of the program.
Data were collected to answer the following key
questions:
1. What is the recovery, reliable improvement and
reliable recovery rates of MindStep™? How do they
compare with the UK IAPT benchmark?
2. What is the enrolment, completion, drop out and
step up rates?
3. Is there an optimal number of sessions to maximise
recovery rates?
4. Do clients with varying initial symptom severity
experience any differences in their recovery rates? If
so, what are the implications for future program
selection criteria?
5. Are the recovery rates relatively consistent across
coaches?
6. Were clients satisfied with MindStep™?
Setting
Six private health funds referred their members from all
over Australia to the program. However, the LiCBT coa-
ches delivered the program from Melbourne MindStep™
office by telephone and the clinical supervisors were
based at Flinders University, Adelaide.
Participants and recruitment
Individuals were identified as eligible for the program
following an acute hospital admission for anxiety and/or
depression, confirmed by the member’s claims data and
ICD-10 codes. Once identified, health funds offered indi-
viduals an opportunity to opt-out via email or telephone,
before passing on their contact details to MindStep™. At
least 5 attempts to contact the client were made by Mind-
Step™ to enrol (with consent) and ensure there were no
contraindications (such as imminent risk to self or others,
active psychosis or chronic substance misuse). At this first
contact, consent for the use of de-identified clinical data
for the purpose of evaluation of the trial was sought from
all client participants. At this time, a further opt-out op-
tion was offered to them which did not affect their receipt
of the intervention; 680 clients provided consent.
Quantitative data collection and analysis
Data sources and variables
With consent and ethics approval, de-identified data
were extracted from the clinical software system from
March 2016 to July 2017. This data included age, sex,
socio-economic status, marital status, employment sta-
tus, assigned coach, number of sessions attended and
clinical measures (PHQ-9, GAD-7) to assess key out-
comes of interest and to determine reasons of ‘end of
care’ (Table 1) in answering the research questions.
Statistical methods
Main analysis
The primary analysis was based on a ‘per-IAPT protocol’
to investigate effect size estimates, recovery rate and reli-
able recovery rate in primary outcomes PHQ-9 and
GAD-7 at post-treatment. This approach sought to esti-
mate treatment effect if all clients completed their ther-
apy providing ‘missing at random’ (MAR; probability of
missing data is dependent on observed values and pos-
sibly covariates but independent of unobserved values
[19]) was a reasonable assumption for treatment non-
adherers. Secondary analyses followed an intent-to-treat
(ITT) principle where all clients were included in the
analysis to avoid potential effects from therapy drop out
[20]. Inferences from ITT analysis are generalizable to
therapy effectiveness in everyday clinical practice but
may underestimate effects in the presence of non- ad-
herence to therapy protocol. We also performed a modi-
fied ITT (mITT) analysis to assess effect estimates when
excluding clients who were stepped up to high intensity
treatment. Statistical analyses were conducted using
Stata 15.1 [21].
Two different approaches were used for ITT analyses
to handle missing PHQ-9 and GAD-7 data. First, the
single imputation method of last observation carried for-
ward (LOCF). Second, multiple imputation (MI) by
chained eqs. A main feature of chained equations is its
ability to handle different variable types (e.g., continuous
and binary) [22]. To reduce the chance of bias from
missing data, multiple imputation by chained equations
with 40 imputations was used [22]. Covariates included
in our imputation models were baseline gender, age,
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SES, employment, PHQ-9, GAD-7, and WSAS.
Post-treatment variables were PHQ-9 and GAD-7. The
results obtained from 40 completed-data analyses were
then combined into a single multiple-imputation result
for effect size, recovery rate and reliable recovery rate.
As MI models were based on the assumption that data
were at least missing at random (MAR), sensitivity ana-
lyses were performed via a pattern mixture approach
with multiple imputation (MI). This was done separately
for PHQ-9 and GAD-7 by (1) imputing the missing re-
sponse values at post-treatment using chained equations
for 40 imputations; (2) checking that these results were
the same as for the linear regression for observed data
only; and (3) for imputed data, increasing the mean re-
sponse above that predicted under MAR, and
re-analysed. If the data were missing not at random
(MNAR; probability of missingness is dependent on both
observed and unobserved values), it was likely that the
mean at post-treatment (for clients for whom it was
missing) was higher than that predicted under MAR.
Utilising the findings from LOCF method, the distribu-
tions N(M = 5.0, SD = 5.0) and N(4.0, 4.0) were used for
PHQ-9 and GAD-7 respectively to summarise the as-
sumed difference between MNAR and MAR. Variants of
these distributions were also tested to reveal the effects
of different levels of uncertainty.
Effect size estimate Cohen’s d was calculated using
one-sample t-test for difference scores between pre- and
post-treatment, assuming null hypothesis equal to zero.
The reason for this approach was to account for depend-
ency or correlation within individual assessment scores.
The t-value was directly used in the formula: d = t/
ffiffiffiffi
N
p
[23]. The 95% confidence intervals were calculated by
finding the non-centrality parameters λlower and λupper
using Stata function npnt(df, t, p) [21] and then trans-
formed back to the effect-size scale with dlower=upper
¼ λlower=upperffiffiffi
N
p . For imputed MI data, Cohen’s d used ad-
justed means and standard errors for the variability be-
tween imputations in an immediate form (i.e., summary
statistics entered as arguments) of a one-sample t-test.
Secondary exploratory analyses
We also used Chi-square and Fisher’s exact test (to
account for low cell counts) [24]. Post-hoc Phi and
Cramer’s V [24] were carried out to determine the as-
sociation between symptom severity and outcomes
and to measure heir effect sizes, using SPSS (v22.0)
[25]. The same tests were used to assess any differ-
ences among coaches’ performance. Finally, General
Linear Model (GLM) [26] was employed to check the
Table 1 Outcomes of interest and definitions of ‘end of care’ categories for analysis
Defining criteria
Measures
Recovery Number of clients who were at or above caseness (PHQ-9 > 9 and/or GAD-7 > 7) before treatment,
then below caseness in both PHQ-9 and GAD-7 after treatment
Reliable improvement Number of clients who demonstrated an improvement of ≥6 on PHQ-9 and/or≥ 4 on GAD-7,
regardless of whether this change meant that they were still in caseness. Reliable improvement refers to
the improvement in the PHQ-9 and GAD-7 scores that is sufficient to conclude that the improvement in
the scores is beyond that which could be attributed to measurement error. It is an important measure
for showing improvement in clients with more severe baseline symptom scores
Reliable recovery Number of clients that both moved to recovery and showed reliable improvement
Clinical software category
Completed all sessions Client has completed at least assessment plus 2 or more treatment sessions (up to a total of 6)
and deactivated as completed.
Completed all sessions and
stepped up to other services
Client completed up to 6 sessions plus assessment (and was considered as completed program)
but also required to be stepped up to higher intensity mental health services.
Not suitable at assessment Client has complex or multi-morbid mental health conditions and deemed unsuitable for MindStep™.
Client declined treatment Client made an informed choice not to participate in MindStep™ after the first assessment or first
treatment session.
Stepped up The service did not meet the clients’ level of clinical need following assessment and before receiving
a minimum of 2 further sessions, and was stepped up to higher intensity mental health services.
DNA Client cancelled in advance of appointment or did not respond to contact attempts at the scheduled
appointment.
Deceased Client is deceased post referral.
Client drop out Client drops out post-assessment before receiving a minimum of 2 further sessions; and unable to
re-establish contact with no response from contact attempts.
Source: National Health Service 2011, UK [18]
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differences among coaches in terms of number of
treatment sessions.
Qualitative data collection
Interviews were conducted with MindStep™ coaches and
clients (including people who dropped out). The aim
was to recruit sufficient client participants to ensure the
capture of views across the range of jurisdictions, and
demographic and clinical features and outcomes from
the intervention. The interviews were guided by a
semi-structured questionnaire that was initially devel-
oped by the clinical supervisor and the qualitative re-
search officer. The questionnaire was further refined by
the team. The key questions were: participants’ experi-
ence of the program; confidence in managing mental
health after the intervention; most and least helpful as-
pects of the program; how the program could be im-
proved; and, any other comments. Client interviews took
place via telephone (as most were outside of South
Australia), whilst coach interviews were undertaken
face-to-face. All interviews lasted between 30 and 60min.
Qualitative data analyses
Interviews were recorded, transcribed and analysed by
Flinders research team members using Framework Ana-
lysis [27], chosen to best answer the established research
questions. The data was independently coded by the
qualitative research officer with input and under the
supervision of the clinical supervisor and the research
leader who had expertise in qualitative methods. To-
gether, they established tentative themes that were then
presented to the remaining research team members for
discussion to ensure rigor as part of the research team
agreeing on and finalising the framework for presenting
the final qualitative findings.
Results
Quantitative findings
Participants
Between March 2016 and July 2017, 867 clients were re-
ferred to MindStep™.757 attended the initial telephone
assessments making an enrolment rate of 87.3%. Of 757
clients, 680 commenced treatment (had at least one
treatment session) with 535 clients continuing the pro-
gram. ‘Reasons for end of care’ showed that of the
remaining clients who attended the initial assessments
(N = 222), 29 (3.8%) were not suitable at assessment, 56
(8.2%) were stepped up, 40 (5.3%) declined further treat-
ment, and 97 (12.8%) dropped out (Fig. 1).
Figure 2 also shows month-wise dropout rates before
and after attending the assessment.
The overall program completion rate was 62.7% as 427
of 680 clients completed treatment (had minimum two
treatment sessions). ‘Reasons for end of care’ also
showed that 50 (7.3%) clients were stepped up after
completing six treatment sessions, and 58 (8.5%) were
active cases at the time of reporting.
Missing data
Although most baseline data was available there was miss-
ing data for employment (105/680, 15.4%), PHQ-9 and
GAD-7 (5/680, 0.7%) and WSAS (10/680, 1.5%). Missing
data rates at post-treatment for primary outcome PHQ-9
was 50/680 (7.4%) and GAD-7 54/680 (7.9%).
Sample characteristics
To analyse the key measures, 680 clients were consid-
ered who entered the treatment; Table 2 presents their
demographics and clinical characteristics.
Additionally, a total of 234 clients (30.9% of 757)
had expressed suicidal ideation or risk symptoms2 at
assessment. Of them, 22 (9.4%) were identified as ‘not
suitable at assessment’; 34 (14.5%) either dropped out
or declined further treatment; 44 (18.8%) were
stepped up after one treatment session; 13 (5.6%)
were stepped up after completing up to 6 treatment
sessions; 90 (38.5%) completed the program while 31
(13.3%) remained ‘active cases’ at the time of report-
ing. There were no completed suicides during the
study period.
Main analysis
Table 3 provides the effect size estimates Cohens d of
pre-post change, recovery rates and reliable recovery
rates with 95% CIs for PHQ-9 and GAD-7, including PP
and ITT analyses. For those clients who adhered to the
IAPT protocol, PP effect sizes were in the large range
based on conventional standards (i.e., d = 0.2 small ef-
fect; d = 0.5 medium effect; d = 0.8 large effect [28]. The
effect size of 1.03 for depression meant that, on average,
those undergoing therapy would improve their score by
+ 1.03 standard deviation units at post-treatment. This is
equivalent to moving from the 50th percentile to the
85th percentile in terms of improvement (reduction) in
PHQ scores [29]. For anxiety, an improvement of + 0.99
standard deviations was comparable to a client moving
from the 50th percentile to the 84th percentile following
therapy. The recovery rate of 66% (95% CI: 61–72%) in-
dicated that this proportion of clients moved from case-
ness at pre-treatment to not being at caseness
post-treatment on both anxiety and depression mea-
sures. The reliable recovery rate of 62% (57–68%) was a
combination of reliable improvement and recovery– the
proportion of clients who showed both a change from
caseness to not being caseness during the course of ther-
apy and who also showed a reliable improvement in
their score(s).
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The mITT analysis included all clients except those
who stepped-up in therapy. Similar to PP results, effect
sizes were in the large range and indicated client PHQ-9
scores improved by + 0.88 standard deviation units (50th
percentile → 81st percentile) at post-treatment. GAD-7
scores improved by + 0.82 standard deviation units (50th
percentile → 79th percentile). The recovery rate was
60% (95% CI: 55–65%) and reliable recovery, 56% (51–
61%). For ITT (i.e., all clients included in the analysis)
using multiply imputed datasets, the PHQ-9 effect size
estimate of 0.78 (50th percentile → 78th percentile) was
in the moderate range as was GAD-7 (0.76; 50th per-
centile → 78th percentile). The recovery rate was 53%
(48–57%) and reliable recovery 49% (45–54%). Overall,
there was an expected decrease in effect size, recovery
rate and reliable recovery rate from PP analysis to the
more conservative ITT analysis using MI method. The
LOCF method provides the most (anti) conservative esti-
mates but should be interpreted with caution as they do
not account for error in imputed values.
Table 4 details results for sensitivity analysis performed
via a pattern mixture approach with multiple
Fig. 1 Clients - flow diagram
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imputation. Using the distributions N(M = 5.0, SD = 5.0)
for PHQ-9 and N(M = 5.0, SD = 5.0) for GAD-7 to sum-
marise the assumed difference between MNAR and
MAR, there were no distinct changes between these esti-
mates and MAR mechanism of missingness. Similar pat-
terns of findings were found when further increasing
the mean response above that predicted under MAR.
In summary, these sensitivity analyses suggest that
findings from MI estimates of recovery rates for
PHQ-9 and GAD-7 were plausible under MAR
assumption.
Secondary exploratory analyses
Symptom severity and treatment outcome The recov-
ery status and its relationship with clients’ initial symp-
tom severity [18] was also analysed for those who
completed treatment (N = 427). Pearson’s chi-square test
showed a significant association between PHQ-9
symptom severity and associated recovery status with a
small effect size for those who were at initial caseness
(N = 247). Clients with ‘moderate symptom’ (10–14) and
‘moderately severe symptom’ (15–19) at baseline PHQ-9
had the highest recovery numbers. Similarly, for GAD-7
(N = 249), clients with ‘mild symptom’ (8–10) and ‘mod-
erate symptom’ (11–15) had the highest recovery num-
bers (Table 5).
Of the 427 clients who completed the program, 282
(66.04%) also showed ‘reliable improvement’, 133 (31.15%)
showed ‘no change’ and only 12 (2.81%) showed ‘reliable
deterioration’ (Additional file 2). Pearson’s chi-square test
showed that there was a strong association between
clients’ PHQ-9 symptom severity and reliable improve-
ment in their scores (N = 343, χ2 = 67.71, Cramer’s V =
0.44, p < 0.001). Clients assessed with ‘moderate’
(64.3%,N = 74), ‘moderately severe’ (77.0%,N = 67) and
‘severe’ depression symptoms (77.8%,N = 35) showed the
most reduction in their PHQ-9 scores (Fig. 3).
Similarly, the test showed that there was a fairly strong
association between clients’ GAD-7 symptom severity
and their reliable improvement (N = 362, χ2 = 63.83,
Cramer’s V = 0.42, p < 0.001). Clients assessed with
‘moderate anxiety’ (81.0%,N = 94) and ‘severe anxiety’
(86.2%,N = 56) showed the most reduction in their
GAD-7 scores (Fig. 4).
Treatment sessions Of 427 clients who completed the
treatment, the mean number of sessions completed was
5.0 (SD = 1.4) across an average duration of 10.5 weeks
(SD = 10.6) with interquartile range (IQR), 1.14–15.7. Also,
62.9% (N = 300) completed all six treatment sessions.
Results showed that more clients who completed six
sessions, reached the recovery threshold compared to
those who had two to five treatment sessions (133 vs 67,
Z = 6.6, p < 0.001). Results were similar for those who re-
liably improved (186 vs 96, Z = 7.57, p < 0.001).
Follow-ups Of 427 clients who completed treatment, 282
(66.0%) also received 1, 3 or 6-months follow-up calls.
Paired samples T-test [30] showed significant difference
between the pre intervention and post follow-up PHQ-9
scores (pre-score = 10.91, post-score = 4.32, mean differ-
ence = 6.59, p < 0.001) and GAD-7 scores (pre-score =
9.14, post-score = 3.68, mean difference = 5.46, p < 0.001).
Coach variance There were seven coaches between
March’16 and July’17 in MindStep™. Fishers’ exact test
[21] showed that coach C had the highest enrolment rate
(92.2%, p = 0.001) but, interestingly, the lowest recovery
rate (31.6%, p = 0.003) (Fig. 5). There was no significant
difference between other coaches’ performance.
Fig. 2 MindStep™ monthly dropout rate
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The test also showed that there was no significant
difference among the coaches for number of clients
who reliably improved, were stepped-up or followed
up (p > 0.05) while taken into account their symptom
severity.
However, GLM [26] showed that there was a signifi-
cant difference among the coaches regarding number of
treatment sessions, while controlling for clients’ symp-
tom severity, age and gender (F = 4.79, p < 0.001). For all
coaches, minimum and maximum number of sessions
Table 2 Demographic and clinical characteristics of 680 clients who entered treatment
Completers
(N = 427)
Non-completers
(N = 253)
Demographic Characteristics % (N) % (N)
Gender
N = 680
Male 59.5 (110) 40.5 (75)
Female 64.0 (317) 36.0 (178)
Marital status
N = 442
Married/DeFacto 70.3 (163) 29.7 (69)
Never married 70.9 (139) 29.1 (57)
Divorced/Widowed 78.6(11) 21.4(3)
Employment status
N = 575
Employed 61.8 (136) 38.2 (84)
Unemployed 68.8 (159) 31.2 (72)
Not stated 67.7 (84) 32.3 (40)
State
N = 680
Queensland 62.5 (80) 37.5 (48)
Victoria 62.7 (168) 37.3 (100)
Western Australia 66.7 (20) 33.3 (10)
New South Wales 61.8 (136) 38.2 (84)
South Australia 70.0 (14) 30.0 (6)
Northern Territory 100.0 (3) 0.0 (0)
Australian Capital Territory 100.0 (1) 0.0 (0)
Tasmania 50.0 (5) 50.0 (5)
Mean (standard deviation)
Age at referral
N = 680
55.5 (15.6) 52.1 (16.3)
SES (Decilea)
N = 680
6.52 (2.9) 6.47 (2.8)
Clinical Characteristics % (N) % (N)
ICD-10
N = 493
Major depressive disorder 61.3 (100) 38.7 (63)
Recurrent episodes of major depression 53.3 (32) 46.7 (28)
Anxiety disorder 70.2 (66) 29.8 (28)
Unspecified mental disorder 49.3 (71) 50.7 (73)
Others (F34/F38/F40/F43/F45) 56.2 (18) 43.8 (14)
PHQ-9 Symptom Severity N = 675 No symptom (0–4) 71.4 (60) 28.6 (24)
Mild symptom (5–9) 73.6 (120) 26.4 (43)
Moderate symptom (10–14) 63.5 (115) 36.5 (66)
Moderately severe (15–19) 54.0 (87) 46.0 (74)
Severe (20–27) 52.3 (45) 47.7 (41)
GAD-7 Symptom Severity N = 670 None (0–4) 72.4 (89) 27.6 (34)
Mild anxiety (5–10) 65.4 (157) 34.6 (83)
Moderate anxiety (11–15) 60.7 (116) 39.3 (75)
Severe anxiety (16–21) 56.0 (65) 44.0 (51)
aSES (Decile): Socio-economic status based on 2016 census data from Australian Bureau of Statistics (ABS), regions (post code) are given an Index of Relative
Socioeconomic Advantage and Disadvantaged (IRSAD) score and assigned to a decile – with 10 representing the most advantaged region, one the
most disadvantaged
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ranged between 2 and 8, with coach E having a signifi-
cantly higher mean number of sessions (N = 6) than
coach A (N = 5, p = 0.001), C (N = 5, p = 0.002) and D
(N = 5, p = 0.011). Here, it is notable that clients of these
later three coaches also had lower recovery rate than cli-
ents of coach E, but there was no statistical significant
difference (p > 0.05).
Qualitative findings
Alongside quantitative methods, this study also
employed qualitative methods to understand the accept-
ance and feasibility of the program. Twenty-one out of
70 randomly selected clients (including dropouts) con-
sented to being interviewed for this part of the study.
However, seven could not be contacted on the day of in-
terviews and thus, a total of 14 clients were interviewed.
Four of the seven coaches were interviewed. At the time
of conducting the interviews, there were four active coa-
ches who were employed from the start of the service,
and they all consented to take part in interviews. The
remaining three coaches started only 3 months prior to
the evaluation and were not approached. Similar to pre-
ceding results, qualitative data also showed positive out-
comes of the program.
Treatment satisfaction Based on the analysis of tran-
scripts of clients’ and coaches’ interviews, key themes
were identified and summarised in Fig. 6. The findings
indicate that clients’ motivation and adherence, coaches’
empathetic and structured yet flexible coaching style,
use of appropriate process and materials, and finally, col-
laboration with the existing health system to be able to
intervene at the ‘right time’- all played important roles
in the perceived success of MindStep™.
Program effectiveness Clients and coaches were con-
sistent in being positive about MindStep™, in particular
how it is perceived amongst users and other health pro-
fessionals. Both clients and coaches reported that symp-
toms of depression and anxiety had been appropriately
diagnosed and managed.
I just found MindStep actually much more valuable
sometimes, and I just thought if only I had done this
first, four years ago, instead of going through all the
other stuff, and dealing through traumas, I honestly
believe that I would have had a different experience in
my recovery. (Client 5)
Well I think the strengths (of the program) are it really
is working. We’re hearing it with our clients. People are
finding that it’s helping them so that’s pretty amazing
and I’m sure that comes from the fact that it is
structured and firmly within a specific scope. (Coach D)
Perception of coaching quality All clients (including
those who dropped out) thought highly of coaches’ pro-
fessionalism and competency. They appreciated the em-
pathy and the ability to build rapport by coaches.
Table 3 Pre-post estimates for symptoms of depression (PHQ-9) and anxiety (GAD-7)
Analytic strategy N ES(PHQ) ES(GAD) N clinical cases Recovery rate Reliable recovery
PP 427 1.03(0.92–1.16) 0.99(0.88–1.11) 301 0.66(0.61–0.72) 0.62(0.57–0.68)
mITTa 584 0.88(0.79-0.98) 0.82(0.71–0.90) 410 0.60(0.55–0.65) 0.56(0.51–0.61)
ITT
MI 680 0.78(0.69–0.86) 0.76(0.67–0.84) 497 0.53(0.48–0.57) 0.49(0.45–0.54)
LOCF 675 0.77(0.68–0.85) 0.75 (0.66–0.83) 497 0.51 (0.46–0.55) 0.47 (0.43–0.51)
Abbreviations: ES Effect size, PHQ-9 Patient health questionnaire-9, Generalised Anxiety Disorder-7 questionnaire, PP Per protocol analysis, (m) ITT (modified) intent-
to-treat analysis, MI Multiple imputation, LOCF Last observation carried forward
aExcluding stepped-up clients (n = 96)
Table 4 Estimated effect of IAPT intervention from regression, multiple imputation under MAR, and multiple imputation under MNAR
Analysis PHQ-9 p GAD-7 p
Estimate 95% CI Estimate 95% CI
LR 0.59 0.52–0.66 < 0.001 0.50 0.43–0.56 < 0.001
MI (MAR) 0.59 0.52–0.66 < 0.001 0.50 0.43–0.56 < 0.001
MI (MNAR)
N(5, 5) 0.59 0.52–0.67 < 0.001 N(4, 4) 0.50 0.43–0.57 < 0.001
N(10, 5) 0.60 0.52–0.67 < 0.001 N(8, 4) 0.51 0.44–0.58 < 0.001
N(10, 20) 0.60 0.50–0.69 < 0.001 N(8, 16) 0.51 0.40–0.61 < 0.001
Abbreviations: PHQ-9 Patient health questionnaire-9, Generalised Anxiety Disorder-7 questionnaire, CI Confidence interval, LR Linear regression, MI Multiple
imputation, MAR Missing at random, MNAR Missing not at random
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She was very professional. We made a time and she’d
ring on time and it was very well run. I can’t say
enough about that…I had a tendency just to go off
track and she was very good, she always pulled me
back in and was obviously trained well. (Client 4)
It always felt like he was there for me, not just for
getting his numbers, like it didn’t seem like it was just
his job, it seemed like he cared as well. (Client 6)
Access Clients valued the ease of access (intervention
via telephone), materials (self-help guides, workbooks,
pre-treatment diary), and delivery technique (shared-de-
cision making process) of MindStep™.
I found it easier over the phone in my own time, in my
own environment. It was a bit more relaxing that way.
(Client 2)
I think the thing that has helped quite a lot were the two
workbooks that I went through and that sort of showed
me the larger body of work that makes it all hang
together…Also, knowing that I’ve got those at my
fingertips. I know where to look in my own time. (Client 7)
Yeah, sort of being in control and being able to work
together in setting the program whereas I think some
people might feel face-to-face the counsellor/psych-
iatrist are running the show so to speak. This way you
got to be a part of your own plan. (Client 9)
Table 5 Clients’ recovery status as per their symptom severity
Recovered
% (N)
Did not recover
% (N)
Statistical analyses
PHQ-9 Symptom severity
Moderate (10–14) 80.8 (93) 19.1 (22) χ2 = 9.77,
Cramer’s V = 0. 19,
p = 0.008Moderately severe (15–19) 67.8 (59) 32.1 (28)
Severe (20–27) 57.7 (26) 42.2 (19)
Total 72.0 (178) 27.9 (69)
GAD-7 Symptom severity
Mild (8–10) 80.8 (55) 19.1 (13) χ2 = 7.92,
Cramer’s V = 0.18,
p = 0.019Moderate (11–15) 68.1 (79) 31.8 (37)
Severe (16–21) 58.4 (38) 41.5 (27)
Total 69.0 (172) 30.9 (77)
Fig. 3 Association between PHQ-9 (Depression) relaible improvement and symptom severity for those who met the improvement criteria (PHQ-9≥ 6)
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Structure Coaches valued the structured framework of
delivery. They mentioned clients appreciated new ideas
about how to manage symptoms and how the structure
increased their faith in the MindStep™ and the coaches.
…things like the maintenance cycle and the rationale
which we do right at the beginning and the problem
statement is often such a-they go like oh yes, you really
heard me and that is my problem and yes that
treatment-that would be amazing…It’s probably that
trust and-it’s not rapport but you’ve sort of proven your
worth quite early on which is a good engagement piece
for the rest of the program. (Coach A)
Coaches perceived that when clients attended regu-
larly, completed their homework and practiced the skills,
they ‘reaped the rewards’. Coaches also found the ability
to tailor their delivery techniques to client needs helpful.
Fig. 4 Association between GAD-7 (Anxiety) relaible improvement and symptom severity for those who met the improvement
criteria (GAD-7≥ 4)
Fig. 5 Coaches’ variances in enrolment and recovery rate
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…within that (structured framework) you still have
the possibility to bring a bit of tailoring and
individual personality and rapport building and
things like the goal setting and getting to know
your client that’s what makes it enjoyable and
rewarding both as a coach and for the client
I’d imagine. (Coach B)
Barriers
Both clients and coaches commented that at times they
struggled with completing the clinical measures (PHQ-9,
GAD-7, WSAS etc.). Clients in particular felt there were
‘too many’ questions and they were ‘repetitive’. One cli-
ent also felt the measures were not a true reflection of
her fluctuating mental state.
…for me it (scores) can change so quickly from
moment to moment almost, that how I felt an hour
ago might be completely different to how I feel now.
(Client 14)
Doing the measures each week-I haven’t actually
heard from the clients too much but that’s annoy-
ing...some mention it. I think maybe as a coach
you’re doing them every day, five or ten times, and
it’s just painful. (Coach C)
Coaches also reported that the process of completing
homework, keeping a diary etc. can be overwhelming for
some clients.
One client who dropped out felt that MindStep™ might
be more suited to a ‘first timer’.
I’ve been in and out of hospital and seen counsellors for
quite a long time and I felt like the content wasn’t new,
that I’d heard it before…If it was someone who is
experiencing depression or anxiety as a result of perhaps
a family death or one thing…that perhaps it might have
been more beneficial for those groups. (Client 14)
Sustainability Clients were confident in the program’s
sustainability. However, coaches were less sure about
how clients would cope during a crisis on their own
after MindStep™ was completed.
The people who are going well, some of them are
honestly so confident with what they’ve learnt that I
do feel confident for them. But there’s also a big
chunk who should a situation arise that’s
particularly stressful or sad as it would be for
anyone I don’t know if they’ve got the resilience
there simply because of the chronic nature of what
they’ve been through. (Coach A)
I’m introducing that (relapse prevention) at say session
6 or session 7-which is fine but you kind of want to
really embed it and I do wonder for some of my clients
whether they’re going to be able to pick that up and
run with it. (Coach C)
One coach suggested adding ‘crisis intervention’ planning
after initial sessions to help cope and respond to future
crisis. Additionally, another suggested better collaboration
with traditional mental health service providers can en-
hance the acceptability and effectiveness of MindStep™.
Fig. 6 Key factors of a successful program
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Discussion
Unlike any other existing LiCBT services that are based
on IAPT, the MindStep™ program is novel because it has
been developed within the private health insurance space,
is completely telephone-based, and serves the needs of
people with not only mild and moderate symptom, but
also more severe depression and anxiety. It also receives
the vast majority of its referrals via private health insurers
for clients identified following hospital discharge.
Key results
The positive findings replicate recovery rates and clinical
outcomes delivered in other settings, and add substan-
tially to the body of knowledge accumulating for LiCBT
and its application in Australia’s mental health stepped
model of care. The findings confirm Mindstep™’s feasibil-
ity and acceptability in the Australian private health sys-
tem, and that it can achieve benchmark recovery rates of
> 50% in people with recent mental health hospital ad-
mission [18]. Our results are also mostly comparable to
the recent Norwegian report [17], using both complete
case and ITT analytic strategies.
Mindstep™ clients’ symptom severity at enrolment is
comparable to the previously reported in the literature
[12, 16, 18], and MindStep™ was also able to achieve
comparable recovery rates of > 50% once the program
was fully established. Qualitative findings confirmed the
acceptance of telephone-based delivery of LiCBT by par-
ticipants and the use MindStep™ coaches who received
accredited mental health training, but did not come
from a traditional mental health service background. In
particular, this approach may help to address the ‘tyr-
anny of distance’, including problems with access to ser-
vices and resourcing issues often experienced within
Australia’s vast rural and remote regions.
Overall, the results showed that clients with ‘moderate’
and ‘moderately severe’ depression (10–19 on PHQ-9)
or ‘mild’ and ‘moderate’ anxiety (8–15 on GAD-7) were
more likely to reach the threshold of ‘recovery’. Also, cli-
ents who had ‘moderately severe’ and ‘severe’ depression
(15–27 on PHQ-9) showed the highest ‘reliable improve-
ment’ in their PHQ-9 scores. Similarly, clients with
‘moderate’ and ‘severe’ anxiety (11–21 on GAD-7)
showed the highest ‘reliable improvement’ in their
GAD-7 scores. The results showed that MindStep™
could result in clinically significant symptom reduction,
whether clients reached the definition threshold for ‘re-
covery’ or not. Hence, measures of recovery and reliable
improvement can both offer meaningful clinical out-
comes to assess mental health interventions for depres-
sion and anxiety.
An international meta-analysis of 16 studies compar-
ing low intensity interventions with usual care found
that patients who had more severe symptoms of
depression at baseline showed at least as much clinical
benefit as those with less severe symptoms, within the
stepped care model [31]. Further research is needed to
understand the cost effectiveness, retention strategies
and referral options of providing LiCBT to people at dif-
ferent symptom thresholds, with an aim to enable every-
one who needs this evidence-based treatment to have
access at a time and place that is convenient to them
[32–34].
MindStep™ can be delivered to large numbers of
people across geographical boundaries for people with
symptoms of depression and anxiety. It could continue
to explore options for serving those clients with more
severe needs; including veterans and others with poten-
tially more complex presentations such as Post Trau-
matic Stress Disorder (PTSD), chronic pain and
post-natal depression. It also has the potential to address
clients’ comorbid mental and physical conditions [33].
This would have implications for coaches’ skillsets, levels
of support and supervision, clinical governance and
management of risk, interactions with other programs,
and the overall development of the clinical model.
Compared to the UK IAPT post-assessment dropout
rate benchmark of 35% [18], MindStep™ showed much
lower dropout rate (12.8%). Of interest, White [34] re-
ported that globally, clients using a primary care clinical
psychology service are more likely to cancel or not attend
their first appointments (17–84%). Thus, dropout between
referral and assessment and soon after assessment, are a
well-known phenomenon within the delivery of psycho-
logical therapies [35, 36]. Also, of these client cohorts, only
17–65% seem to complete all treatment sessions, which is
comparable to MindStep™ completion rate of 62.9%.
Of the other variables investigated, this analysis showed
that coaches who provided five sessions or more of LiCBT,
achieved higher client recovery rates. Therefore, clients
should be encouraged to complete a minimum of five ses-
sions. Battersby et al. [37] found that improved outcomes
from this sort of problem-solving therapy were associated
with an increased number of sessions. However, there was
no significant difference between coaches’ performances
based on clients’ reliable improvement, step-up or
follow-up numbers when controlling for clients’ symptom
severity. Except for one coach, there was also no signifi-
cant difference in their clients’ enrolment and recovery
rate. To enhance the role of coaches and to ensure effect-
ive and consistent coaching to address variations across
coaches and within individual coaches, more shadowing,
mentoring and transition steps to accommodate the learn-
ing and support needs of new coaches could be employed
in the future.
The qualitative findings showed that the coaches were
keys to the success of the program. The coaches’ inter-
views revealed that even though the model itself was
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well structured and formulated, it also required some per-
sonalisation to client need. If a client sticks with the plan
and cooperates with the coach, he or she is likely to get a
more positive outcome. However, even when the program
finishes, the client would require practicing their newly
learnt tool of ‘self-management’ to keep them moving for-
ward. This suggests a clear need to improve transfer and
communication with the person’s primary healthcare pro-
vider or others who may be involved in supporting their
ongoing mental health and wellbeing.
Thus, the results of this study suggest a number of is-
sues for improvement of the MindStep™ program. Firstly,
the program should continue to target clients across the
existing range of severity of conditions and explore op-
tions for clearly defined clinical pathways for those with
more severe needs. MindStep™ should increase accessi-
bility to men clients as well. It should also and consider
expanding to include after-hours delivery of service to
some clients. The program should be promoted on a lar-
ger scale to help mental health professionals to better
understand the program. In particular, this should in-
clude how the program is complementary to traditional
services, not conflicting or competing with these ser-
vices. Because it is a totally phone-based service, Mind-
Step™ can reach a large number of the target population,
especially those living in remote areas. A Dutch qualitative
study using Normalisation Process Theory to investigate
the implementation of stepped care in primary care found
that primary care clinicians’ increased awareness and un-
derstanding of stepped care (inclusive of LiCBT services)
improved their ability to differential patient groups, target
antidepressant prescribing more effectively, and have bet-
ter working relationships with patients and colleagues. A
range of barriers were also identified, suggesting areas for
more intensive focus and support, such as addressing atti-
tudes, service culture, competition between disciplines,
and poor organisational infrastructure that hampered ef-
fective communication [38, 39].
For clients, the service could consider how it can be
tailored to accommodate the needs of clients with
lower literacy levels, inclusive of coach training to sup-
port more flexible delivery of the program to these cli-
ents. During the pilot phase, LiCBT workbooks
developed by Exeter University in the UK were used to
deliver the service, with cases and support information
tailored to the UK context. This is not ideal and, there-
fore, Australian versions of the workbooks have been
developed by Flinders University. Each of these work-
books, and the sessions in which they are used by coa-
ches and clients, have a clear focus on crisis
intervention and relapse prevention as part of closure
and transfer work with clients. The next step should be
to support online availability of the workbooks to en-
able their completion electronically by clients.
Strengths and limitations
A key strength of this study is that the findings provide
essential precursors to high quality clinical trials - a
much needed step to developing the trajectory of IAPT
research in the Australian context. On this note, we pre-
sented ITT findings as secondary data due to the obser-
vational nature of our study design. A future RCT would
afford more robust data concerning therapy effectiveness
from an ITT perspective.
A limitation was the use of the single imputation
method LOCF. This approach misses the informative
properties of missingness and does not account for error
in imputed values. However, we included LOCF findings
to provide an opportunity for comparison with other
missing data techniques- namely multiple imputation and
complete case analysis. Our findings suggested that LOCF
estimates were indeed anti-conservative by introducing
bias from “worse than true (but missing)” values [40].
One of the study’s other inherent limitations was the
absence of a control group. A further limitation was the
use of the self-reported PHQ-9 and GAD-7 as key mea-
sures for determining clinical levels of depression
(PHQ-9 > 9) and anxiety (GAD-7 > 7). Although they
have good psychometric properties, Richards & Borglin
[30] remind us that they do not formally diagnose pa-
tients. Rodgers et al’s [41] systematic review recom-
mended that future studies should include “participants
in remission or recovery from depression, and evaluate
the quality of the intervention and consistency of deliv-
ery across practitioners where appropriate. The occur-
rence of relapse or recurrence should be measured using
established methods” (p.1). For our study, diagnoses
(ICD-10) were available only at baseline from the exter-
nal referral sources (hospitals etc.) and were not rou-
tinely collected as part of the IAPT protocol. Further
longitudinal study is also required to determine the pro-
gram’s potential to reduce hospital readmissions and as-
sociated costs.
Also, this evaluation did not consider the needs of cli-
ents from non-English speaking backgrounds or Indi-
genous populations. Further adaptation of the processes
and materials used in the service, and their evaluation, is
needed. More generally, the potential impact of client lit-
eracy levels was not included in this analysis, even
though it is known to be important for promoting access
to this type of service [6]. Further research is also
needed to understand coach qualities and actions that
may influence client outcomes. Gellatly et al. [14] have
indicated that little is known about these aspects of
LiCBT and what role non-specific coach factors might
play, though qualifications and background of coaches
appears to make little difference to client outcomes. Fur-
ther research is also needed on whether the mode of de-
livery of LiCBT matters to client outcomes.
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Conclusions
MindStep™ appears to be a promising telephone-based
LiCBT intervention for people who have had a recent
hospital admission for anxiety and/or depression. The
results of this evaluation are encouraging and suggest
that telephone-based LiCBT is acceptable, feasible and
effective at addressing the mental health needs of people
to bridge a gap in the transition from acute to commu-
nity based mental health care. It appears to add an im-
portant component within the suite of options of
Australia’s stepped approach to mental health care;
therefore, replication and further evaluation, including
more longitudinal follow-up data to investigate to the
stability of improvements, is warranted. This type of ser-
vice is also important for Australia because of its geog-
raphy as a large country with several rural and remote
communities that are underserved by the healthcare sys-
tem, and that have poorer health outcomes as a conse-
quence of that geography.
Endnotes
1MindStep™ was developed by Remedy Healthcare, a
wholly owned subsidiary of Australian Unity. Remedy is a
leading provider of highly targeted, evidence-based health
coaching programs and out of hospital care for people
with long term conditions to support their capacity for
self-management. These programs have been funded by
private health insurers, employers, aged care providers
and other corporate health organisations since 2008.
2Suicide symptoms were determined by the PHQ-9
last question that asked ‘thoughts that you would be bet-
ter off dead or hurting yourself in some way- not at
all=0, several days=1, more than half the days=2, nearly
every day=3’. Clients with a score higher than 0 are re-
ported here.
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